Literature DB >> 31064261

Evaluation of HIV Reporting Form in Sana'a City, Yemen, 2016.

Mahmoud Hassan Abdulrazzak1, Abdul Hamid Alsahybi2, Ali Assabri1, Yousef Khader3.   

Abstract

Yemen has witnessed a significant rise in AIDS-related deaths because of very poor access to antiretroviral treatment and because of the current war situation. This study aimed to assess the attributes of human immunodeficiency virus (HIV) reporting form, including usefulness, simplicity, flexibility, and acceptability, which is used for reporting HIV cases in Sana'a, Yemen. A descriptive cross-sectional study was conducted among 311 physicians from public and private health facilities in Sana'a city. Physicians were interviewed using a structured questionnaire to assess the form's attributes. The mean score was calculated for each attribute and converted to percentages which were interpreted as very poor, poor, average, good, and excellent. The usefulness overall score was 76%, indicating average usefulness. Of the total participants, 283 (91%) and 304 (97.7%) stated that the form is clear and easy to fill, respectively. More than two-thirds (68.5%) of physicians stated that the form ensures the privacy of the customer's identity. The simplicity attribute score was 74.5%, indicating average simplicity. The overall flexibility was 69.2%, indicating average flexibility. A total of 175 (56%) physicians indicated that they are completely satisfied with the reporting form. The acceptability score was 75.2%, indicating that the HIV/AIDS reporting form of HIV is average in acceptability. The HIV/AIDS reporting form in Yemen was scored average in usefulness, simplicity, flexibility, and acceptability. Training health workers on using the reporting form would improve the performance of HIV/AIDS reporting. Moreover, the reporting form could be adapted to be integrated with other surveillance such as tuberculosis surveillance.

Entities:  

Keywords:  HIV; Yemen; evaluation; field epidemiology training program; reporting form

Mesh:

Substances:

Year:  2019        PMID: 31064261      PMCID: PMC6506924          DOI: 10.1177/0046958019847020

Source DB:  PubMed          Journal:  Inquiry        ISSN: 0046-9580            Impact factor:   1.730


What do we already know about this topic? An efficient human immunodeficiency virus (HIV)/AIDS surveillance system is needed to control HIV spread. How does your research contribute to the field? The performance of HIV reporting form in Yemen is assessed using Centers for Disease Control and Prevention (CDC) guidelines for evaluation of the public health surveillance system. What are your research’s implications toward theory, practice, or policy? Policy makers in Yemen should consider the findings of this evaluation to improve the HIV reporting process.

Introduction

Human immunodeficiency virus (HIV)/AIDS is a leading cause of disease burden and mortality in many countries of the world.[1] The number of people living with HIV/AIDS has been increasing and reached 36.7 million at the end of 2016.[2] At the same time, HIV/AIDS mortality has been declining from a peak of 1.8 million deaths in 2005 to 1.2 million deaths in 2015.[3] In the Middle East and North Africa (MENA) region, 230 000 people were estimated to live with HIV in 2015. In the same year, there were about 21 000 new HIV infections and 12 000 AIDS-related deaths.[4] Despite that MENA had a low HIV prevalence, it becomes an area of concern because of the rise in AIDS-related deaths as a result of poor access to antiretroviral treatment (ART), with only 24% of those requiring ART in the region having access—far below the global level of 53%.[5] Since the detection of the first HIV case in Yemen in 1987, the Ministry of Public Health and Population (MoPHP) established the National AIDS Program (NAP) to monitor and control HIV spreads. The major activities of NAP included providing antiretroviral therapy for people living with HIV in 5 governorates, providing voluntary counseling and testing, providing initiated testing and counseling services at 36 sites in several governorates, and prevention of mother-to-child transmission. In 2004, the program followed the Primary Health Care Directorate. The program receives reports every 3 months from different NAP sites. According to the 2011 HIV estimates of NAP, Yemen had a low prevalence of HIV (0.2%).[6] A total of 3995 HIV cases were reported during the years 1987-2013.[7] It is evident that a very rigorous, advanced, and consistent surveillance system is needed to control HIV spread. The system needs to go beyond the detection of infected cases to plunge in the inherent root causes and risk behaviors that stimulate the progression of the epidemic.[4] A standardized form is cornerstone to ensure standard data collection. This study aimed to determine the usefulness of the HIV reporting form and assess its performance in Sana’a city according to Centers for Disease Control and Prevention (CDC) guidelines.

Methods

Study Design

A descriptive cross-sectional study was conducted to evaluate the performance of HIV reporting form in Yemen using CDC guidelines for evaluation of the public health surveillance system.[8]

Data Collection

All public health facilities (8 governmental hospitals, 2 district hospitals, 34 health centers) and all private health facilities in Sana’a City were visited by the investigator as the first step. All stakeholders who are responsible for HIV reporting in their health facilities and who had ever used HIV reporting from were identified and invited to participate in the study. A structured questionnaire was used to collect the necessary data from various stakeholders from public and private health facilities in Sana’a city. A total of 311 physicians, 153 men (49%) and 158 women (51%), were eligible and were interviewed (response rate = 100%). The questionnaire consisted of a number of items assessing the performance attributes of HIV reporting form using CDC guidelines, including usefulness, simplicity, flexibility, and acceptability. The 5-point Likert-type scale (1 = strongly disagree, 2 = disagree, 3 = not sure, 4 = agree, 5 = strongly agree) was used to rate the questionnaire items. The mean score was calculated for each attribute and converted to percentages to show the score. Based on the percentages, the score was interpreted as very poor (<40%), poor (40%-<60%), average (60-<80%), good (80%-90%), and excellent (>90%). Data were analyzed using Epi info version 7, and data were described using means, frequencies, and proportions.

Results

Participants’ Characteristics

A total of 311 physicians from several public and private health facilities in Sana’a city were interviewed. Of the men, 108 (71%) were general practitioners (GP) and 45 (29%) were specialists. Of the women, 127 (80%) were GPs and 31 (20%) were specialists. The distribution of participants according to health facility is shown in Table 1.
Table 1.

Distribution of Participants by Type of Health Facility in Sana’a City, 2016.

Sex
Male
Female
Total
Type and kind of health facilityNo.%No.%No.%
Public hospitals8556664215149
Private hospitals4529563510132
Public health centers64117176
Private health centers171125164214
Total153100158100311100
Distribution of Participants by Type of Health Facility in Sana’a City, 2016.

Usefulness

A total of 279 (89.7%) physicians stated that the surveillance data are useful for decision makers and 180 (57.9%) stated that the data help to identify the areas at greater risk (Table 2). The overall usefulness score was 76%, indicating average usefulness.
Table 2.

Usefulness, Simplicity, Flexibility, and Acceptability of Human Immunodeficiency Virus Reporting Form, Yemen 2016.

Attribute/statement
Strongly disagree/disagree
Not sure
Agree/strongly agree
UsefulnessNo.%No.%No.%
Data form is useful for decision makers31299.327989.7
The form is identifying areas at greater risk92.912239.218057.9
Simplicity
 The form is clear175.5113.528391
 The form is easy to fill20.651.630497.7
 The form ensures the privacy of customer’s identity31106721.521368.5
 The form is detailed92.93511.326785.9
 The form contains sufficient data196.17323.521970.4
 Filling out the form needs a trained specialist10533.88828.311837.9
 Notification form has case definition of the problem81261123611837.9
Flexibility
 HIV/AIDS case definition is easy to apply309.68527.319663
 HIV tests mentioned in the form are enough165.14012.925582
 In case of having case definition, it is applicable165.112640.516954.3
 You can add other data in this form3410.910734.417054.7
 The form adapted to integrate with other surveillance such as tuberculosis268.416151.812439.9
Acceptability
 You do not mind to fill this form72.3227.128290.7
 You are completely satisfied with HIV surveillance system form175.511938.317556.3
Usefulness, Simplicity, Flexibility, and Acceptability of Human Immunodeficiency Virus Reporting Form, Yemen 2016.

Simplicity

Of the total participants, 283 (91.0%) and 304 (97.7%) stated that the form is clear and easy to fill, respectively. More than two-thirds (68.5%) of the physicians stated that the form ensures privacy. The majority (85.9%) stated that the form is detailed and 71% stated that the form contains sufficient data. A total of 118 (37.9%) participants reported that filling the form needs a trained specialist, 118 (37.9%) reported that notification form has case definition of the problem, 196 (63.0%) reported that HIV/AIDS case definition is easy to apply, and 255 (82.0%) said that the form contains enough HIV tests for diagnosis (Table 2). The overall simplicity score was 74.5%, indicating average simplicity.

Flexibility

Of the 311 participants, 169 (54.3%) mentioned that case definition is applicable. More than half (55%) stated that it is possible to add other data to the reporting form and 108 (35%) mentioned that the reporting form could be adapted to be integrated with other surveillance such as tuberculosis surveillance (Table 2). The overall flexibility score was 69.2%, indicating average flexibility.

Acceptability

Regarding the participants’ willingness to fill the reporting form, 282 (91%) were willing to do that. A total of 175 (56%) physicians indicated that they are completely satisfied with the reporting form (Table 2). The acceptability score was 75.2%, indicating that the HIV/AIDS reporting form of HIV surveillance system acceptability is average.

Summary of the Performance Attributes

Table 3 shows the summary of the performance attributes of HIV reporting form according to sex of physicians and type of health facility. The overall performance scores for usefulness, simplicity, flexibility, and acceptability did not differ significantly between physicians according to sex and type of health facility.
Table 3.

Summary of the Performance Attributes of Human Immunodeficiency Virus Reporting Form According to Sex of Physicians and Type of Health Facility.

AttributesVariables
p value
Hospitals, %Health centers, %
Usefulness76.475.7.955
Simplicity65.962.7.754
Flexibility69.668.0.934
Acceptability75.573.0.816
Public, %Private, %
Usefulness75.477.0.944
Simplicity64.666.0.906
Flexibility68.470.4.902
Acceptability74.575.4.970
Male, %Female, %
Usefulness75.876.2.960
Simplicity75.573.8.830
Flexibility73.471.5.804
Acceptability75.475.1.944
Summary of the Performance Attributes of Human Immunodeficiency Virus Reporting Form According to Sex of Physicians and Type of Health Facility.

Discussion

This study showed that the HIV/AIDS reporting form was clear and easy to fill. This finding was reported in another study in Portugal.[9] The simplicity of the reporting form was average. For improving the simplicity of the form, HIV/AIDS case definition should be modified and written in the reporting form. The form was found to contain detailed and sufficient data. This finding is not in agreement with the findings of another study in Italy.[10] In agreement with the findings of a study in St. Lucia,[11] the form was found to ensure privacy of patients. However, the form does not have a clear case definition. Therefore, the HIV/AIDS case should be made more clear. Regarding the flexibility of the HIV/AIDS reporting form, HIV case definition was applicable. Adding other necessary data to the reporting form was reported to be possible. It is recommended to adapt the reporting form to be integrated with other surveillance such as tuberculosis surveillance. The physicians showed willingness to use the reporting form. However, almost half of the participants were completely satisfied with the HIV surveillance system form. This finding might be due to inadequate health workers’ knowledge and experience in dealing with this form. Therefore, training health professionals on the reporting form and increasing their awareness on the value of reporting are expected to improve the acceptability. One of the main limitations of this study is that not all performance attributes of the surveillance system were assessed, such as completeness, accuracy and reliability of data, and timeliness. In conclusion, the HIV/AIDS reporting form of the HIV surveillance system was scored average in usefulness, simplicity, flexibility, and acceptability. The HIV/AIDS case definition should be modified and written in the reporting form. Training health workers on using the reporting form would improve the performance of HIV/AIDS reporting. Moreover, the reporting form could be adapted to be integrated with other surveillance such as tuberculosis surveillance.
  5 in total

1.  Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group.

Authors:  R R German; L M Lee; J M Horan; R L Milstein; C A Pertowski; M N Waller
Journal:  MMWR Recomm Rep       Date:  2001-07-27

2.  Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013.

Authors:  Louisa Degenhardt; Fiona Charlson; Jeff Stanaway; Sarah Larney; Lily T Alexander; Matthew Hickman; Benjamin Cowie; Wayne D Hall; John Strang; Harvey Whiteford; Theo Vos
Journal:  Lancet Infect Dis       Date:  2016-09-21       Impact factor: 25.071

3.  HIV surveillance and epidemic profile in the Middle East and North Africa.

Authors:  Sherine Shawky; Cherif Soliman; Kassem M Kassak; Doaa Oraby; Danielle El-Khoury; Inoussa Kabore
Journal:  J Acquir Immune Defic Syndr       Date:  2009-07-01       Impact factor: 3.731

4.  Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet HIV       Date:  2016-07-19       Impact factor: 12.767

5.  Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors:  Christopher J L Murray; Katrina F Ortblad; Caterina Guinovart; Stephen S Lim; Timothy M Wolock; D Allen Roberts; Emily A Dansereau; Nicholas Graetz; Ryan M Barber; Jonathan C Brown; Haidong Wang; Herbert C Duber; Mohsen Naghavi; Daniel Dicker; Lalit Dandona; Joshua A Salomon; Kyle R Heuton; Kyle Foreman; David E Phillips; Thomas D Fleming; Abraham D Flaxman; Bryan K Phillips; Elizabeth K Johnson; Megan S Coggeshall; Foad Abd-Allah; Semaw Ferede Abera; Jerry P Abraham; Ibrahim Abubakar; Laith J Abu-Raddad; Niveen Me Abu-Rmeileh; Tom Achoki; Austine Olufemi Adeyemo; Arsène Kouablan Adou; José C Adsuar; Emilie Elisabet Agardh; Dickens Akena; Mazin J Al Kahbouri; Deena Alasfoor; Mohammed I Albittar; Gabriel Alcalá-Cerra; Miguel Angel Alegretti; Zewdie Aderaw Alemu; Rafael Alfonso-Cristancho; Samia Alhabib; Raghib Ali; Francois Alla; Peter J Allen; Ubai Alsharif; Elena Alvarez; Nelson Alvis-Guzman; Adansi A Amankwaa; Azmeraw T Amare; Hassan Amini; Walid Ammar; Benjamin O Anderson; Carl Abelardo T Antonio; Palwasha Anwari; Johan Arnlöv; Valentina S Arsic Arsenijevic; Ali Artaman; Rana J Asghar; Reza Assadi; Lydia S Atkins; Alaa Badawi; Kalpana Balakrishnan; Amitava Banerjee; Sanjay Basu; Justin Beardsley; Tolesa Bekele; Michelle L Bell; Eduardo Bernabe; Tariku Jibat Beyene; Neeraj Bhala; Ashish Bhalla; Zulfiqar A Bhutta; Aref Bin Abdulhak; Agnes Binagwaho; Jed D Blore; Berrak Bora Basara; Dipan Bose; Michael Brainin; Nicholas Breitborde; Carlos A Castañeda-Orjuela; Ferrán Catalá-López; Vineet K Chadha; Jung-Chen Chang; Peggy Pei-Chia Chiang; Ting-Wu Chuang; Mercedes Colomar; Leslie Trumbull Cooper; Cyrus Cooper; Karen J Courville; Benjamin C Cowie; Michael H Criqui; Rakhi Dandona; Anand Dayama; Diego De Leo; Louisa Degenhardt; Borja Del Pozo-Cruz; Kebede Deribe; Don C Des Jarlais; Muluken Dessalegn; Samath D Dharmaratne; Uğur Dilmen; Eric L Ding; Tim R Driscoll; Adnan M Durrani; Richard G Ellenbogen; Sergey Petrovich Ermakov; Alireza Esteghamati; Emerito Jose A Faraon; Farshad Farzadfar; Seyed-Mohammad Fereshtehnejad; Daniel Obadare Fijabi; Mohammad H Forouzanfar; Urbano Fra Paleo; Lynne Gaffikin; Amiran Gamkrelidze; Fortuné Gbètoho Gankpé; Johanna M Geleijnse; Bradford D Gessner; Katherine B Gibney; Ibrahim Abdelmageem Mohamed Ginawi; Elizabeth L Glaser; Philimon Gona; Atsushi Goto; Hebe N Gouda; Harish Chander Gugnani; Rajeev Gupta; Rahul Gupta; Nima Hafezi-Nejad; Randah Ribhi Hamadeh; Mouhanad Hammami; Graeme J Hankey; Hilda L Harb; Josep Maria Haro; Rasmus Havmoeller; Simon I Hay; Mohammad T Hedayati; Ileana B Heredia Pi; Hans W Hoek; John C Hornberger; H Dean Hosgood; Peter J Hotez; Damian G Hoy; John J Huang; Kim M Iburg; Bulat T Idrisov; Kaire Innos; Kathryn H Jacobsen; Panniyammakal Jeemon; Paul N Jensen; Vivekanand Jha; Guohong Jiang; Jost B Jonas; Knud Juel; Haidong Kan; Ida Kankindi; Nadim E Karam; André Karch; Corine Kakizi Karema; Anil Kaul; Norito Kawakami; Dhruv S Kazi; Andrew H Kemp; Andre Pascal Kengne; Andre Keren; Maia Kereselidze; Yousef Saleh Khader; Shams Eldin Ali Hassan Khalifa; Ejaz Ahmed Khan; Young-Ho Khang; Irma Khonelidze; Yohannes Kinfu; Jonas M Kinge; Luke Knibbs; Yoshihiro Kokubo; S Kosen; Barthelemy Kuate Defo; Veena S Kulkarni; Chanda Kulkarni; Kaushalendra Kumar; Ravi B Kumar; G Anil Kumar; Gene F Kwan; Taavi Lai; Arjun Lakshmana Balaji; Hilton Lam; Qing Lan; Van C Lansingh; Heidi J Larson; Anders Larsson; Jong-Tae Lee; James Leigh; Mall Leinsalu; Ricky Leung; Yichong Li; Yongmei Li; Graça Maria Ferreira De Lima; Hsien-Ho Lin; Steven E Lipshultz; Shiwei Liu; Yang Liu; Belinda K Lloyd; Paulo A Lotufo; Vasco Manuel Pedro Machado; Jennifer H Maclachlan; Carlos Magis-Rodriguez; Marek Majdan; Christopher Chabila Mapoma; Wagner Marcenes; Melvin Barrientos Marzan; Joseph R Masci; Mohammad Taufiq Mashal; Amanda J Mason-Jones; Bongani M Mayosi; Tasara T Mazorodze; Abigail Cecilia Mckay; Peter A Meaney; Man Mohan Mehndiratta; Fabiola Mejia-Rodriguez; Yohannes Adama Melaku; Ziad A Memish; Walter Mendoza; Ted R Miller; Edward J Mills; Karzan Abdulmuhsin Mohammad; Ali H Mokdad; Glen Liddell Mola; Lorenzo Monasta; Marcella Montico; Ami R Moore; Rintaro Mori; Wilkister Nyaora Moturi; Mitsuru Mukaigawara; Kinnari S Murthy; Aliya Naheed; Kovin S Naidoo; Luigi Naldi; Vinay Nangia; K M Venkat Narayan; Denis Nash; Chakib Nejjari; Robert G Nelson; Sudan Prasad Neupane; Charles R Newton; Marie Ng; Muhammad Imran Nisar; Sandra Nolte; Ole F Norheim; Vincent Nowaseb; Luke Nyakarahuka; In-Hwan Oh; Takayoshi Ohkubo; Bolajoko O Olusanya; Saad B Omer; John Nelson Opio; Orish Ebere Orisakwe; Jeyaraj D Pandian; Christina Papachristou; Angel J Paternina Caicedo; Scott B Patten; Vinod K Paul; Boris Igor Pavlin; Neil Pearce; David M Pereira; Aslam Pervaiz; Konrad Pesudovs; Max Petzold; Farshad Pourmalek; Dima Qato; Amado D Quezada; D Alex Quistberg; Anwar Rafay; Kazem Rahimi; Vafa Rahimi-Movaghar; Sajjad Ur Rahman; Murugesan Raju; Saleem M Rana; Homie Razavi; Robert Quentin Reilly; Giuseppe Remuzzi; Jan Hendrik Richardus; Luca Ronfani; Nobhojit Roy; Nsanzimana Sabin; Mohammad Yahya Saeedi; Mohammad Ali Sahraian; Genesis May J Samonte; Monika Sawhney; Ione J C Schneider; David C Schwebel; Soraya Seedat; Sadaf G Sepanlou; Edson E Servan-Mori; Sara Sheikhbahaei; Kenji Shibuya; Hwashin Hyun Shin; Ivy Shiue; Rupak Shivakoti; Inga Dora Sigfusdottir; Donald H Silberberg; Andrea P Silva; Edgar P Simard; Jasvinder A Singh; Vegard Skirbekk; Karen Sliwa; Samir Soneji; Sergey S Soshnikov; Chandrashekhar T Sreeramareddy; Vasiliki Kalliopi Stathopoulou; Konstantinos Stroumpoulis; Soumya Swaminathan; Bryan L Sykes; Karen M Tabb; Roberto Tchio Talongwa; Eric Yeboah Tenkorang; Abdullah Sulieman Terkawi; Alan J Thomson; Andrew L Thorne-Lyman; Jeffrey A Towbin; Jefferson Traebert; Bach X Tran; Zacharie Tsala Dimbuene; Miltiadis Tsilimbaris; Uche S Uchendu; Kingsley N Ukwaja; Selen Begüm Uzun; Andrew J Vallely; Tommi J Vasankari; N Venketasubramanian; Francesco S Violante; Vasiliy Victorovich Vlassov; Stein Emil Vollset; Stephen Waller; Mitchell T Wallin; Linhong Wang; XiaoRong Wang; Yanping Wang; Scott Weichenthal; Elisabete Weiderpass; Robert G Weintraub; Ronny Westerman; Richard A White; James D Wilkinson; Thomas Neil Williams; Solomon Meseret Woldeyohannes; John Q Wong; Gelin Xu; Yang C Yang; Yuichiro Yano; Gokalp Kadri Yentur; Paul Yip; Naohiro Yonemoto; Seok-Jun Yoon; Mustafa Younis; Chuanhua Yu; Kim Yun Jin; Maysaa El Sayed Zaki; Yong Zhao; Yingfeng Zheng; Maigeng Zhou; Jun Zhu; Xiao Nong Zou; Alan D Lopez; Theo Vos
Journal:  Lancet       Date:  2014-07-22       Impact factor: 79.321

  5 in total
  2 in total

1.  Intestinal microsporidiosis among HIV/AIDS patients receiving antiretroviral therapy in Sana'a city, Yemen: first report on prevalence and predictors.

Authors:  Kwkab A R Al-Brhami; Rashad Abdul-Ghani; Salah A Al-Qobati
Journal:  BMC Infect Dis       Date:  2022-01-04       Impact factor: 3.090

2.  The realities of HIV prevention. A closer look at facilitators and challenges faced by HIV prevention programmes in Sudan and Yemen.

Authors:  Fatima Bashir; Maha Ba Wazir; Barbara Schumann; Kristina Lindvall
Journal:  Glob Health Action       Date:  2019       Impact factor: 2.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.